TMSP(SH:600671) Sou Hu Cai Jing·2025-05-25 20:05Group 1 - The stock price of Tianmu Pharmaceutical (600671) closed at 12.35 yuan on May 23, 2025, down 0.64%, with a turnover rate of 4.2% and a trading volume of 51,100 shares, amounting to a transaction value of 64.27 million yuan [1] - As of May 20, 2025, the number of registered shareholders of the company was 9,075 [2] - The company’s subsidiary, Tianmu Mountain Health Technology (Shenzhen) Co., Ltd., has registered several trademarks in the pet and health food industries, indicating a potential entry into these markets [2] - The company is focused on the research, production, and sales of pharmaceuticals, raw materials, and health products, while also engaging in drug circulation and medical technology services [2] Group 2 - The company is monitoring market dynamics and regulatory changes, particularly the newly released "Major Asset Restructuring Management Measures" by the CSRC, and will comply with disclosure obligations if relevant matters arise [2] - The company acknowledged that stock price fluctuations in the secondary market are influenced by macroeconomic conditions, industry status, and market expectations [3] - On May 23, 2025, the net capital flow for Tianmu Pharmaceutical showed a net outflow of 6.177 million yuan from institutional investors and a net inflow of 6.9742 million yuan from retail investors [4][5]